Validation of the RIETE, Kuijer, and HAS-BLED Models to Assess 3-Month Bleeding Risk in Anticoagulated Patients Diagnosed with Venous Thromboembolic Disease.

9 All of these have shown acceptable performance in the populations in which they were initially developed, but they have not been externally validated to determine their applicability in the Latin American population, where there may be significant differences in different aspects such as the frequency of use of direct anticoagulants, accessibility to the health system, educational or socioeconomic level of the patients, characteristics that have been associated with the frequency of hemorrhagic complications. 10 The purpose of this study

also in 13,097 other papers